openPR Logo
Press release

Non-Invasive Prenatal Testing (NIPT) Market Forecast 2017-2021

06-01-2017 12:22 PM CET | Health & Medicine

Press release from: SA-BRC

Non-Invasive Prenatal Testing (NIPT) Market Forecast

Non-invasive prenatal testing (NIPT) has received importance in the recent past due to increasing awareness about genetic disorders and availability of accurate noninvasive tests. NIPT testing is non-invasive has no risk of miscarriage as compared to other tests such as chorionic villus sampling (CVS) or amniocentesis. Down syndrome is one of most commonly diagnosed using NIPT. Some of the key genetic disorders diagnosed using NIPT include Edward's syndrome, Patau syndrome and Down syndrome. Advancing maternal age has increased risk of genetic disorders among neonatal. Average age of first time mothers is increasing globally due to diversified culture and increasing number of working women. Centers for Disease Control and Prevention (CDC) also states that the risk for Down syndrome increases with age of mother, with sharp increase after 30 years of age. Greece, Australia, South Korea, Japan, Italy, Switzerland, Luxemburg, Singapore, Spain and Ireland are 10 leading countries with average pregnant women age 30 years and above. Hence prevalence of genetic disorders such as Down syndrome is expected to be high in these regions.

Request Free Report Sample@ http://www.sa-brc.com/Global-Non-Invasive-Prenatal-Testing-NIPT-Market-Assessment--Forecast-2017-2021/up109

Popularity of the test is high in the North American and Europe where there is increased awareness about genetic disorders and genetic tests. Hence these regions lead the global non-invasive prenatal testing market. With prior awareness about genetic disorders in fetus, family can plan medical treatment that may help patients with Down syndrome in living a productive life in the future. There are various families in the U.S. who are looking forward to adopt children with Down syndrome as a social service. National Down Syndrome Network is a leading organization in the U.S. assisting with adoptions. With prior diagnosis through NIPT, parents can make timely arrangements for adoption. Although NIPT provides accurate screening of certain genetic disorders, it is also observed that various mothers have found themselves under dilemma after NIPT screening tests. False positive tests are common and confirmation tests are usually recommended in case of positive NIPT screening. These tests have high risk of miscarriage, and not covered by major insurance providers. These factors may impede the growth of non-invasive prenatal testing market.

Some of the key brands available in the market include MaterniT21 PLUS, Bambni Test, Veracity, NIFTY, Panorama, informaSeq and various others. Increasing popularity has added new players to the market in the recent past. Considering more than 200 million pregnancies annually, there exists immense potential for NIPT market growth. Key players in the non-invasive prenatal testing market include Ariosa Diagnostics, Genesis Genetics, Natera, Inc., Sequenom Laboratories and BGI Diagnosis Co., Ltd.

Request For TOC@ http://www.sa-brc.com/Global-Non-Invasive-Prenatal-Testing-NIPT-Market-Assessment--Forecast-2017-2021/upcomingdetail109

NOTE: This report is currently under research and will be made available to clients on request.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
India
Phone: +91-02041210872
Email: support@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Invasive Prenatal Testing (NIPT) Market Forecast 2017-2021 here

News-ID: 559401 • Views: 283

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for NIPT

Non-invasive Prenatal Testing (NIPT) Market - Screening Opportunities 2025
Global Non-invasive Prenatal Testing (NIPT) Market: Overview The growing preference for non-invasive techniques over invasive surgeries is one of the key growth drivers for the global non-invasive prenatal testing (NIPT) market. In addition to this number of babies born with Down syndrome, XYY syndrome, Turner, and Klinefelter is increasing, boosting the growth of the market. These chromosomal aneuploidies occur as a result of infertility, reproductive loss, and language development delays
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk
Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022
Global Non-invasive Prenatal Testing Market: Snapshot Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93 Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100 Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports. NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at a